ClinicalTrials.gg
RecruitingNCT07732374Updated Jul 28, 2026

Long-Term Outcomes Following HBOT

A Phase 2 interventional study of Hyperbaric Oxygen Therapy (HBOT) in Traumatic Brain Injury, Post-Concussive Symptoms and Post-Traumatic Stress Disorder, sponsored by Summit Hyperbarics and Wellness. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-28.

Primary conditionPost-Concussion SyndromeRegistry: Brain Injuries, TraumaticReclassifiedWhy we changed it
Registry
Brain Injuries, Traumatic — the first condition term the registry derived for this study.
ClinicalTrials.gg
Post-Concussion Syndrome
Why
  1. The study's listed conditions name Post-Concussion Syndrome, a narrower term within Brain Injuries, Traumatic.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Summit Hyperbarics and Wellness · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 77 studies in Post-Concussion Syndrome with a site in United States — 15 open to participants now, 20 under way, 1 of them phase 3. Post-Concussion Syndrome · United States.

Planned enrollment
34th of 61
35 · median 40
Started
2026
with 6 others
Phase 2
14 of 77
5 open now
Primary completion
2027-06
later than 9 of 19 live
Registered
73rd of 77
by date
Lead sponsor
4 of 77
Summit Hyperbarics and Wellness

Among the 77 studies in Post-Concussion Syndrome with a site in United States, this one is the 34th largest by planned enrollment of the 61 interventional ones that give a count, is one of 7 that started in 2026, is one of 14 in phase 2, reaches primary completion later than 9 of the 19 other live ones, and was the 73rd registered.

Post-Concussion Syndrome

140 studies on the registry are indexed under Post-Concussion Syndrome; 33 are open to participants now.

Browse Post-Concussion Syndrome studies →

Open to participants now

15 of the 77 studies in Post-Concussion Syndrome with a site in United States are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 24 Post-Concussion Syndrome studies recruiting now, 3 (13%) set no upper age limit and 20 (83%) stop at 75 or younger; 2 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 77 studies in Post-Concussion Syndrome with a site in United States, or all of them as a file.
02

Study summary

This study is designed to better understand the long-term effects of hyperbaric oxygen therapy (HBOT). Our goal is to determine whether improvements after treatment are maintained over time and whether additional benefits appear months after treatment has ended. We will evaluate changes in cognitive function, mental health, and daily functioning to help strengthen the scientific evidence supporting the use of HBOT and guide future treatment recommendations.

Read the detailed description

This study is designed to evaluate the long-term effects of hyperbaric oxygen therapy (HBOT) following the completion of treatment. While previous research has demonstrated promising improvements, less is known about whether these benefits are sustained over time or whether additional improvements continue to emerge after treatment has ended.

The primary objective of this study is to evaluate the persistence of therapeutic effects following the completion of Hyperbaric Oxygen Therapy (HBOT) in veterans, with a focus on cognitive function and symptom reduction related to PTSD, depression, and anxiety. Follow-up assessments will be conducted 12 weeks post-treatment to determine the durability of these outcomes.

The second objective is to evaluate potential delayed (latency) effects of HBOT on cognitive performance, psychological symptoms (e.g., PTSD, depression, anxiety), and functional status.

The findings of this study will help identify the persistence of treatment effects, characterize the timeline of durability, and strengthen the scientific evidence supporting the long-term use of HBOT for individuals with traumatic brain injury, persistent post-concussive symptoms, and post-traumatic stress disorder.

03

Conditions studied

  • Traumatic Brain Injury
  • Post-Concussive Symptoms
  • Post-Traumatic Stress Disorder

Keywords

  • Hyperbaric Oxygen Therapy
  • Treatment Durability
  • Cognitive Function
  • Mental Health
  • Quality of Life
  • Veterans
  • Traumatic Brain Injury
  • Persistent Post-Concussive Symptoms (PCS)
04

In context

Post-Concussion Syndrome Reclassified

140 studies on the registry are indexed under Post-Concussion Syndrome; 33 are open to participants now.

This study's planned enrollment of 35 is below the median of 52 across 113 interventional studies indexed under Post-Concussion Syndrome.

Browse Post-Concussion Syndrome studies →

Lead sponsor

Summit Hyperbarics and Wellness is the lead sponsor of 4 studies on the registry; 4 are open to participants now.

Compared within Post-Concussion Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Brain Injuries, Traumatic. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. At least 18 years of age.
  2. Veteran status
  3. Clinically diagnosed with a mTBI, PCS, PTSD, Anxiety, or Depression disorder.
  4. Successfully completed the parent Hyperbaric Oxygen Therapy (HBOT) intervention, consisting of the full study treatment protocol (40 HBOT sessions).
  5. Willing and able to read, understand, and provide written for participation in the 12-week follow-up study. Additionally, the Participant has clear consciousness and the ability to express self-feelings independently.
  6. Completed cognitive and psychological measurements.
  7. Clinical diagnoses cause significant impairment in social or occupational functioning or some other functional capacity.
  8. Stability on any current psychoactive medications (antidepressants, anti-anxiety medications, antipsychotics, stimulants, and mood stabilizers).

Exclusion criteria

Exclusion Criteria:

  1. Acute medical illness or infection
  2. Severe or unstable physical disorders or major cognitive deficits
  3. Current manic, psychotic episodes, or serious suicidal ideations
  4. Non-English speakers
  5. Inability to attend scheduled follow-up visits
  6. Significant life events, new neurological injury, or new psychiatric diagnosis or hospitalization occurring after completion of the HBOT intervention that, in the opinion of the investigator, could confound cognitive, psychological, or quality-of-life outcomes.
  7. Participation in another interventional clinical study or receipt of a therapeutic intervention following completion of HBOT that could influence cognitive, psychological, or quality-of-life outcomes.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (estimated)

Study arms

  • Experimental
    HBOT Follow-Up Cohort

    Veterans who previously completed a standardized Hyperbaric Oxygen Therapy (HBOT) treatment protocol and undergo follow-up assessments approximately 12 weeks after their final treatment session to evaluate the long-term durability of cognitive, psychological, and quality-of-life outcomes.

    Drug: Hyperbaric Oxygen Therapy (HBOT)

Interventions

  • DrugHyperbaric Oxygen Therapy (HBOT)

    Hyperbaric Oxygen Therapy (HBOT): Participants will receive 100% medical oxygen (USP) administered under hyperbaric conditions at 2.0 atmospheres absolute (ATA) for 60 minutes with a scheduled air break over 40 treatment sessions.

    Also known as: Hyperbaric Oxygen, Hyperbaric Oxygen Treatment

07

What researchers measure

Primary outcomes

  1. NeuroTrax

    A computerized cognitive test to measure various cognitive functions, including memory, executive functioning, visual-spatial perception, verbal function, attention, information processing speed, and motor skills.

    Time frame: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session

  2. PTSD Checklist for DSM-5 (PCL-5)

    Self-report questionnaire to assess symptoms of PTSD

    Time frame: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session

  3. Patient Health Questionnaire-9 (PHQ-9)

    Self-report questionnaire to assess depression severity

    Time frame: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session

  4. Generalized Anxiety Disorder 7-item scale (GAD-7)

    Self-report questionnaire to measure anxiety severity

    Time frame: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session

  5. World Health Organization Quality of Life (WHOQOL-BREF)

    Self-report questionnaire to rate a person's perception of his/her position in their life in the context of physical, psychological, level of independence, social relationships, and environment facets

    Time frame: Baseline (post-HBOT completion) and 12 weeks after the final HBOT session

08

Study locations

1 of 1 sites recruiting
09

References and documents

Individual participant data

Plan to share: No — Given that our study involves a relatively small cohort of veterans and includes sensitive cognitive and mental health data, we selected "no" to share IPD with other researchers.

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Jun 2027, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2026
First posted
Jul 28, 2026
StartActual
Jun 18, 2026
Primary completionEst.
Jun 18, 2027
CompletionEst.
Jun 18, 2027
Last update
Jul 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07732374
Lead sponsor
Summit Hyperbarics and Wellness
Responsible party
Steve Wyman (Principal Investigator, Summit Hyperbarics and Wellness) — Principal investigator
First posted
Jul 28, 2026
Start date
Jun 18, 2026
Primary completion
Jun 18, 2027 (estimated)
Completion
Jun 18, 2027 (estimated)
Last update
Jul 28, 2026

Study contacts

Troy Nickel, PhD
Contact
tnickel@shwidaho.org
208-813-9541

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion